-
1
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Non-small Cell Lung Cancer Collaborative Group
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
2
-
-
4344567395
-
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
-
DOI 10.1200/JCO.2004.08.067
-
Gurubhagavatula S., Liu G., Park S., Zhou W., Su L., Wain J.C., et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004;22:2594-2601 (Pubitemid 41103746)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.13
, pp. 2594-2601
-
-
Gurubhagavatula, S.1
Liu, G.2
Park, S.3
Zhou, W.4
Su, L.5
Wain, J.C.6
Lynch, T.J.7
Neuberg, D.S.8
Christiani, D.C.9
-
3
-
-
56149087582
-
Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy
-
Wu X., Lu C., Ye Y., Chang J., Yang H., Lin J., et al. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics 2008;18:955-965
-
(2008)
Pharmacogenet Genomics
, vol.18
, pp. 955-965
-
-
Wu, X.1
Lu, C.2
Ye, Y.3
Chang, J.4
Yang, H.5
Lin, J.6
-
4
-
-
79952251471
-
Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: A systematic review and meta-analysis
-
Wei S.Z., Zhan P., Shi M.Q., Shi Y., Qian Q., Yu L.K., et al. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: A systematic review and meta-analysis. Med Oncol 2010;28:315-321
-
(2010)
Med Oncol
, vol.28
, pp. 315-321
-
-
Wei, S.Z.1
Zhan, P.2
Shi, M.Q.3
Shi, Y.4
Qian, Q.5
Yu, L.K.6
-
5
-
-
58849149494
-
Pharmacogenetics and pharmacogenomics of anticancer agents
-
Huang R.S., Ratain M.J. Pharmacogenetics and pharmacogenomics of anticancer agents. CA Cancer J Clin 2009;59:42-55.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 42-55
-
-
Huang, R.S.1
Ratain, M.J.2
-
6
-
-
67651213976
-
Platinum pathway
-
Marsh S., McLeod H., Dolan E., Shukla S.J., Rabik C.A., Gong L., et al. Platinum pathway. Pharmacogenet Genomics 2009;19:563-564
-
(2009)
Pharmacogenet Genomics
, vol.19
, pp. 563-564
-
-
Marsh, S.1
McLeod, H.2
Dolan, E.3
Shukla, S.J.4
Rabik, C.A.5
Gong, L.6
-
7
-
-
67349215472
-
Role of copper transporters in resistance to platinating agents
-
Rabik C.A., Maryon E.B., Kasza K., Shafer J.T., Bartnik C.M., Dolan M.E. Role of copper transporters in resistance to platinating agents. Cancer Chemother Pharmacol 2009;64:133-142
-
(2009)
Cancer Chemother Pharmacol
, vol.64
, pp. 133-142
-
-
Rabik, C.A.1
Maryon, E.B.2
Kasza, K.3
Shafer, J.T.4
Bartnik, C.M.5
Dolan, M.E.6
-
8
-
-
34247882838
-
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer
-
PII 0124389420060900000013
-
Booton R., Ward T., Heighway J., Ashcroft L., Morris J., Thatcher N. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer. J Thorac Oncol 2006;1:679-683 (Pubitemid 47163956)
-
(2006)
Journal of Thoracic Oncology
, vol.1
, Issue.7
, pp. 679-683
-
-
Booten, R.1
Ward, T.2
Heighway, J.3
Ashcroft, L.4
Morris, J.5
Thatcher, N.6
-
9
-
-
30744451927
-
Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma
-
DOI 10.1002/cncr.21619
-
Lu C., Spitz M.R., Zhao H., Dong Q., Truong M., Chang J.Y., et al. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer 2006;106:441-447 (Pubitemid 43100456)
-
(2006)
Cancer
, vol.106
, Issue.2
, pp. 441-447
-
-
Lu, C.1
Spitz, M.R.2
Zhao, H.3
Dong, Q.4
Truong, M.5
Chang, J.Y.6
Blumenschein Jr., G.R.7
Hong, W.K.8
Wu, X.9
-
10
-
-
77949674534
-
Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy
-
Moyer A.M., Sun Z., Batzler A.J., Li L., Schaid D.J., Yang P., et al. Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev 2010;19:811-821
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, pp. 811-821
-
-
Moyer, A.M.1
Sun, Z.2
Batzler, A.J.3
Li, L.4
Schaid, D.J.5
Yang, P.6
-
11
-
-
58049209898
-
Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy
-
Kim H.T., Lee J.E., Shin E.S., Yoo Y.K., Cho J.H., Yun M.H., et al. Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy. J Clin Oncol 2008;26:5972-5979
-
(2008)
J Clin Oncol
, vol.26
, pp. 5972-5979
-
-
Kim, H.T.1
Lee, J.E.2
Shin, E.S.3
Yoo, Y.K.4
Cho, J.H.5
Yun, M.H.6
-
12
-
-
78049423379
-
Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer
-
Li F., Sun X., Sun N., Qin S., Cheng H., Feng J., et al. Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. Am J Clin Oncol 2010;33:489-494
-
(2010)
Am J Clin Oncol
, vol.33
, pp. 489-494
-
-
Li, F.1
Sun, X.2
Sun, N.3
Qin, S.4
Cheng, H.5
Feng, J.6
-
13
-
-
79957745242
-
Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
-
Liu L., Yuan P., Wu C., Zhang X., Wang F., Guo H., et al. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 2011;73:110-115
-
(2011)
Lung Cancer
, vol.73
, pp. 110-115
-
-
Liu, L.1
Yuan, P.2
Wu, C.3
Zhang, X.4
Wang, F.5
Guo, H.6
-
14
-
-
34548724426
-
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer
-
DOI 10.1093/hmg/ddm190
-
Matakidou A., el Galta R., Webb E.L., Rudd M.F., Bridle H., Eisen T., et al. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet 2007;16:2333-2340 (Pubitemid 47423899)
-
(2007)
Human Molecular Genetics
, vol.16
, Issue.19
, pp. 2333-2340
-
-
Matakidou, A.1
El, G.R.2
Webb, E.L.3
Rudd, M.F.4
Bridle, H.5
Eisen, T.6
Houlston, R.S.7
-
15
-
-
79951875424
-
Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer
-
Shiraishi K., Kohno T., Tanai C., Goto Y., Kuchiba A., Yamamoto S., et al. Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2010;28:4945-4952
-
(2010)
J Clin Oncol
, vol.28
, pp. 4945-4952
-
-
Shiraishi, K.1
Kohno, T.2
Tanai, C.3
Goto, Y.4
Kuchiba, A.5
Yamamoto, S.6
-
16
-
-
67449162069
-
Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
-
Sun X., Li F., Sun N., Shukui Q., Baoan C., Jifeng F., et al. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients. Lung Cancer 2009;65:230-236
-
(2009)
Lung Cancer
, vol.65
, pp. 230-236
-
-
Sun, X.1
Li, F.2
Sun, N.3
Shukui, Q.4
Baoan, C.5
Jifeng, F.6
-
17
-
-
41549095093
-
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
-
DOI 10.1158/1078-0432.CCR-07-1364
-
Tibaldi C., Giovannetti E., Vasile E., Mey V., Laan A.C., Nannizzi S., et al. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res 2008;14:1797-1803 (Pubitemid 351469466)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.6
, pp. 1797-1803
-
-
Tibaldi, C.1
Giovannetti, E.2
Vasile, E.3
Mey, V.4
Laan, A.C.5
Nannizzi, S.6
Di, M.R.7
Antonuzzo, A.8
Orlandini, C.9
Ricciardi, S.10
Del, T.M.11
Peters, G.J.12
Falcone, A.13
Danesi, R.14
-
18
-
-
0032587083
-
1-antitrypsin deficiency allele carriers among lung cancer patients
-
Yang P., Wentzlaff K.A., Katzmann J.A., Marks R.S., Allen M.S., Lesnick T.G., et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999;8:461-465 (Pubitemid 29230552)
-
(1999)
Cancer Epidemiology Biomarkers and Prevention
, vol.8
, Issue.5
, pp. 461-465
-
-
Yang, P.1
Wentzlaff, K.A.2
Katzmann, J.A.3
Marks, R.S.4
Allen, M.S.5
Lesnick, T.G.6
Lindor, N.M.7
Myers, J.L.8
Wiegert, E.9
Midthun, D.E.10
Thibodeau, S.N.11
Krowka, M.J.12
-
19
-
-
22244461873
-
1-antitrypsin and neutrophil elastase imbalance and lung cancer risk
-
DOI 10.1378/chest.128.1.445
-
Yang P., Bamlet W.R., Sun Z., Ebbert J.O., Aubry M.C., Krowka M.J., et al. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest 2005;128:445-452 (Pubitemid 40994509)
-
(2005)
Chest
, vol.128
, Issue.1
, pp. 445-452
-
-
Yang, P.1
Bamlet, W.R.2
Sun, Z.3
Ebbert, J.O.4
Aubry, M.-C.5
Taylor, W.R.6
Marks, R.S.7
Deschamps, C.8
Swensen, S.J.9
Wieben, E.D.10
Cunningham, J.M.11
Melton, L.J.12
De Andrade, M.13
-
20
-
-
44349108422
-
1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk
-
DOI 10.1001/archinte.168.10.1097
-
Yang P., Sun Z., Krowka M.J., Aubry M.C., Bamlet W.R., Wampfler J.A., et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008;168:1097-1103 (Pubitemid 351749227)
-
(2008)
Archives of Internal Medicine
, vol.168
, Issue.10
, pp. 1097-1103
-
-
Yang, P.1
Sun, Z.2
Krowka, M.J.3
Aubry, M.-C.4
Bamlet, W.R.5
Wampfler, J.A.6
Thibodeau, S.N.7
Katzmann, J.A.8
Allen, M.S.9
Midthun, D.E.10
Marks, R.S.11
De Andrade, M.12
-
21
-
-
52049100798
-
Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression
-
Li L., Fridley B., Kalari K., Jenkins G., Batzler A., Safgren S., et al. Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression. Cancer Res 2008;68:7050-7058
-
(2008)
Cancer Res
, vol.68
, pp. 7050-7058
-
-
Li, L.1
Fridley, B.2
Kalari, K.3
Jenkins, G.4
Batzler, A.5
Safgren, S.6
-
22
-
-
70450189297
-
Gemcitabine and arabinosylcytosin pharmacogenomics: Genomewide association and drug response biomarkers
-
Li L., Fridley B.L., Kalari K., Jenkins G., Batzler A., Weinshilboum R.M., et al. Gemcitabine and arabinosylcytosin pharmacogenomics: Genomewide association and drug response biomarkers. PLoS One 2009;4:e7765.
-
(2009)
PLoS One
, vol.4
-
-
Li, L.1
Fridley, B.L.2
Kalari, K.3
Jenkins, G.4
Batzler, A.5
Weinshilboum, R.M.6
-
23
-
-
78649300012
-
Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
-
Niu N., Qin Y., Fridley B.L., Hou J., Kalari K.R., Zhu M., et al. Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 2010;20:1482-1492
-
(2010)
Genome Res
, vol.20
, pp. 1482-1492
-
-
Niu, N.1
Qin, Y.2
Fridley, B.L.3
Hou, J.4
Kalari, K.R.5
Zhu, M.6
-
24
-
-
34548256353
-
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach
-
DOI 10.1086/519850
-
Huang R.S., Duan S., Shukla S.J., Kistner E.O., Clark T.A., Chen T.X., et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007;81:427-437 (Pubitemid 47330203)
-
(2007)
American Journal of Human Genetics
, vol.81
, Issue.3
, pp. 427-437
-
-
Huang, R.S.1
Duan, S.2
Shukla, S.J.3
Kistner, E.O.4
Clark, T.A.5
Chen, T.X.6
Schweitzer, A.C.7
Blume, J.E.8
Dolan, M.E.9
-
26
-
-
33845225116
-
Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata
-
DOI 10.1086/510257
-
Schaid D.J., Batzler A.J., Jenkins G.D., Hildebrandt M.A. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. Am J Hum Genet 2006;79:1071-1080 (Pubitemid 44853478)
-
(2006)
American Journal of Human Genetics
, vol.79
, Issue.6
, pp. 1071-1080
-
-
Schaid, D.J.1
Batzler, A.J.2
Jenkins, G.D.3
Hildebrandt, M.A.T.4
-
27
-
-
84969213492
-
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
-
Wellcome Trust Case Control Consortium
-
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678
-
(2007)
Nature
, vol.447
, pp. 661-678
-
-
-
28
-
-
77954531945
-
A quality control algorithm for filtering SNPs in genome-wide association studies
-
Pongpanich M., Sullivan P.F., Tzeng J.Y. A quality control algorithm for filtering SNPs in genome-wide association studies. Bioinformatics 2010;26:1731-1737
-
(2010)
Bioinformatics
, vol.26
, pp. 1731-1737
-
-
Pongpanich, M.1
Sullivan, P.F.2
Tzeng, J.Y.3
-
29
-
-
33746512512
-
Principal components analysis corrects for stratification in genome-wide association studies
-
DOI 10.1038/ng1847, PII NG1847
-
Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909 (Pubitemid 44141658)
-
(2006)
Nature Genetics
, vol.38
, Issue.8
, pp. 904-909
-
-
Price, A.L.1
Patterson, N.J.2
Plenge, R.M.3
Weinblatt, M.E.4
Shadick, N.A.5
Reich, D.6
-
30
-
-
78649508578
-
MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes
-
Li Y., Willer C.J., Ding J., Scheet P., Abecasis G.R. MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-834
-
(2010)
Genet Epidemiol
, vol.34
, pp. 816-834
-
-
Li, Y.1
Willer, C.J.2
Ding, J.3
Scheet, P.4
Abecasis, G.R.5
-
31
-
-
84975742565
-
A map of human genome variation from population-scale sequencing
-
Durbin R.M., Abecasis G.R., Altshuler D.L., Auton A., Brooks L.D., Gibbs R.A., et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-1073
-
(2010)
Nature
, vol.467
, pp. 1061-1073
-
-
Durbin, R.M.1
Abecasis, G.R.2
Altshuler, D.L.3
Auton, A.4
Brooks, L.D.5
Gibbs, R.A.6
-
32
-
-
4143051317
-
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
-
DOI 10.1158/1078-0432.CCR-04-0247
-
Zhou W., Gurubhagavatula S., Liu G., Park S., Neuberg D.S., Wain J.C., et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 2004;10:4939-4943 (Pubitemid 39099767)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.15
, pp. 4939-4943
-
-
Zhou, W.1
Gurubhagavatula, S.2
Liu, G.3
Park, S.4
Neuberg, D.S.5
Wain, J.C.6
Lynch, T.J.7
Su, L.8
Christiani, D.C.9
-
33
-
-
3042616025
-
Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity
-
DOI 10.1158/0008-5472.CAN-04-0340
-
Dolan M.E., Newbold K.G., Nagasubramanian R., Wu X., Ratain M.J., Cook E.H. Jr, et al. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. Cancer Res 2004;64:4353-4356 (Pubitemid 38802443)
-
(2004)
Cancer Research
, vol.64
, Issue.12
, pp. 4353-4356
-
-
Dolan, M.E.1
Newbold, K.G.2
Nagasubramanian, R.3
Wu, X.4
Ratain, M.J.5
Cook Jr., E.H.6
Badner, J.A.7
-
34
-
-
40049084479
-
Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis
-
DOI 10.1097/FPC.0b013e3282f5e605, PII 0121301120080300000010
-
Shukla S.J., Duan S., Badner J.A., Wu X., Dolan M.E. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Pharmacogenet Genomics 2008;18:253-262 (Pubitemid 351323240)
-
(2008)
Pharmacogenetics and Genomics
, vol.18
, Issue.3
, pp. 253-262
-
-
Shukla, S.J.1
Duan, S.2
Badner, J.A.3
Wu, X.4
Dolan, M.E.5
-
35
-
-
54049083902
-
Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans
-
Huang R.S., Duan S., Kistner E.O., Hartford C.M., Dolan M.E. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol Cancer Ther 2008;7:3038-3046
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 3038-3046
-
-
Huang, R.S.1
Duan, S.2
Kistner, E.O.3
Hartford, C.M.4
Dolan, M.E.5
-
36
-
-
65249086733
-
Whole-genome approach implicates CD44 in cellular resistance to carboplatin
-
Shukla S.J., Duan S., Wu X., Badner J.A., Kasza K., Dolan M.E. Whole-genome approach implicates CD44 in cellular resistance to carboplatin. Hum Genomics 2009;3:128-142
-
(2009)
Hum Genomics
, vol.3
, pp. 128-142
-
-
Shukla, S.J.1
Duan, S.2
Wu, X.3
Badner, J.A.4
Kasza, K.5
Dolan, M.E.6
-
37
-
-
57149114316
-
Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines
-
Choy E., Yelensky R., Bonakdar S., Plenge R.M., Saxena R., De Jager P.L., et al. Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines. PLoS Genet 2008;4:e1000287.
-
(2008)
PLoS Genet
, vol.4
-
-
Choy, E.1
Yelensky, R.2
Bonakdar, S.3
Plenge, R.M.4
Saxena, R.5
De Jager, P.L.6
-
38
-
-
4043128071
-
Genetic analysis of genome-wide variation in human gene expression
-
DOI 10.1038/nature02797
-
Morley M., Molony C.M., Weber T.M., Devlin J.L., Ewens K.G., Spielman R.S., et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004;430:743-747 (Pubitemid 39071339)
-
(2004)
Nature
, vol.430
, Issue.7001
, pp. 743-747
-
-
Morloy, M.1
Molony, C.M.2
Weber, T.M.3
Devlin, J.L.4
Ewens, K.G.5
Spielman, R.S.6
Cheung, V.G.7
-
39
-
-
41349095280
-
Genetics of gene expression and its effect on disease
-
DOI 10.1038/nature06758, PII NATURE06758
-
Emilsson V., Thorleifsson G., Zhang B., Leonardson A.S., Zink F., Zhu J., et al. Genetics of gene expression and its effect on disease. Nature 2008;452:423-428 (Pubitemid 351450845)
-
(2008)
Nature
, vol.452
, Issue.7186
, pp. 423-428
-
-
Emilsson, V.1
Thorleifsson, G.2
Zhang, B.3
Leonardson, A.S.4
Zink, F.5
Zhu, J.6
Carlson, S.7
Helgason, A.8
Walters, G.B.9
Gunnarsdottir, S.10
Mouy, M.11
Steinthorsdottir, V.12
Eiriksdottir, G.H.13
Bjornsdottir, G.14
Reynisdottir, I.15
Gudbjartsson, D.16
Helgadottir, A.17
Jonasdottir, A.18
Jonasdottir, A.19
Styrkarsdottir, U.20
Gretarsdottir, S.21
Magnusson, K.P.22
Stefansson, H.23
Fossdal, R.24
Kristjansson, K.25
Gislason, H.G.26
Stefansson, T.27
Leifsson, B.G.28
Thorsteinsdottir, U.29
Lamb, J.R.30
Gulcher, J.R.31
Reitman, M.L.32
Kong, A.33
Schadt, E.E.34
Stefansson, K.35
more..
-
40
-
-
0031911792
-
Zip kinase, a novel serine/threonine kinase which mediates apoptosis
-
Kawai T., Matsumoto M., Takeda K., Sanjo H., Akira S. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 1998;18:1642-1651 (Pubitemid 28100930)
-
(1998)
Molecular and Cellular Biology
, vol.18
, Issue.3
, pp. 1642-1651
-
-
Kawai, T.1
Matsumoto, M.2
Takeda, K.3
Sanjo, H.4
Akira, S.5
-
41
-
-
35948986807
-
ZIPK: A unique case of murine-specific divergence of a conserved vertebrate gene
-
DOI 10.1371/journal.pgen.0030180
-
Shoval Y., Pietrokovski S., Kimchi A. ZIPK: A unique case of murine-specific divergence of a conserved vertebrate gene. PLoS Genet 2007;3:1884-1893 (Pubitemid 350072054)
-
(2007)
PLoS Genetics
, vol.3
, Issue.10
, pp. 1884-1893
-
-
Shoval, Y.1
Pietrokovski, S.2
Kimchi, A.3
-
42
-
-
0035835823
-
DAP kinase - A proapoptotic gene that functions as a tumor suppressor
-
DOI 10.1006/excr.2000.5134
-
Raveh T., Kimchi A. DAP kinase-a proapoptotic gene that functions as a tumor suppressor. Exp Cell Res 2001;264:185-192 (Pubitemid 32989091)
-
(2001)
Experimental Cell Research
, vol.264
, Issue.1
, pp. 185-192
-
-
Raveh, T.1
Kimchi, A.2
-
43
-
-
0037078325
-
DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals
-
Wang W.J., Kuo J.C., Yao C.C., Chen R.H. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 2002;159:169-179
-
(2002)
J Cell Biol
, vol.159
, pp. 169-179
-
-
Wang, W.J.1
Kuo, J.C.2
Yao, C.C.3
Chen, R.H.4
-
44
-
-
3042515471
-
DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death
-
DOI 10.1016/j.semcancer.2004.04.008, PII S1044579X04000252
-
Bialik S., Kimchi A. DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Semin Cancer Biol 2004;14:283-294 (Pubitemid 38824589)
-
(2004)
Seminars in Cancer Biology
, vol.14
, Issue.4
, pp. 283-294
-
-
Bialik, S.1
Kimchi, A.2
-
45
-
-
0038075462
-
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
-
DOI 10.1038/nm852
-
Taniguchi T., Tischkowitz M., Ameziane N., Hodgson S.V., Mathew C.G., Joenje H., et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003;9:568-574 (Pubitemid 36597103)
-
(2003)
Nature Medicine
, vol.9
, Issue.5
, pp. 568-574
-
-
Taniguchi, T.1
Tischkowitz, M.2
Ameziane, N.3
Hodgson, S.V.4
Mathew, C.G.5
Joenje, H.6
Mok, S.C.7
D'Andrea, A.D.8
-
46
-
-
33644824212
-
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group
-
Ramirez J.L., Rosell R., Taron M., Sanchez-Ronco M., Alberola V., De Las Penas R., et al. 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. J Clin Oncol 2005;23:9105-9112
-
(2005)
J Clin Oncol
, vol.23
, pp. 9105-9112
-
-
Ramirez, J.L.1
Rosell, R.2
Taron, M.3
Sanchez-Ronco, M.4
Alberola, V.5
De Las Penas, R.6
|